SYNCOPE: WHAT HAPPENS WHEN YOUR LIGHTS GO OUT  ? Syed Raza MD,MRCP (UK),FCCP, Dip.Card (UK)
COMMON SCENARIO ! <ul><li>Elderly lady  </li></ul><ul><li>Lives alone </li></ul><ul><li>Collapse at home  </li></ul><ul><l...
Case    Mrs L, 64yo F                 66yo F         ,        Mrs K,  59yo F               Mrs M,  85yo F           ? Seiz...
 
 
 
 
 
 
 
 
Objectives <ul><li>Definition </li></ul><ul><li>Prevalence </li></ul><ul><li>Diagnostic Work Up </li></ul><ul><li>Manageme...
Syncope: A Symptom, Not a Diagnosis <ul><li>Self-limited loss of consciousness and postural tone </li></ul><ul><li>Relativ...
Impact of Syncope 1 Kenny RA, Kapoor WN. In: Benditt D, et al. eds.  The Evaluation and   Treatment of Syncope . Futura;20...
THE  COST <ul><li>More than 1 billion pounds per year  spent by NHS  for managing falls  and syncope. </li></ul><ul><li>Si...
Incidence Rates of Syncope According to Age and Sex Soteriades, E. et al. N Engl J Med 2002;347:878-885
 
Classification Syncope Neurally Mediated 34% Vasovagal Carotid Sinus Situational Glossopharyngeal Neuralgia Cerebrovascula...
Causes of syncope*   <ul><li>Neurally mediated 50% </li></ul><ul><li>Cardiac arrhythmia 11% </li></ul><ul><li>Orthostatic ...
Neurally Mediated Syncope <ul><li>Neuro cardiogenic syncope  </li></ul><ul><li>Carotid sinus hypersensitivity </li></ul><u...
Neurally Mediated Syncope (autonomic failure) <ul><li>Orthostatic /Postural  Hypotension </li></ul><ul><li>Postural  Ortho...
Neuro-Cardiogenic Syncope <ul><li>Commonest cause of syncope  </li></ul><ul><li>Most frequently in 30 - 50 age group </li>...
Pathophysiology <ul><li>Neuro-cardiovascular reflexes severely impaired or absent. </li></ul><ul><li>Pooling of  500-800 m...
Carotid Sinus Syndrome <ul><li>Common in elderly/atherosclerotic ds. </li></ul><ul><li>Sensitive baro receptors at carotid...
Carotid Sinus Syncope and Autonomic Dysfunction Freeman, M.  Neurogenic Orthostatic Hypotension.  NEJM 2008; 358: 616
 
POSTURAL  BP
 
Postural Blood Pressure <ul><li>Sadly NOT  accurately measured </li></ul><ul><li>Supine position –at least 10 minutes </li...
Orthostatic Hypotension <ul><li>Common in elderly </li></ul><ul><li>most vulnerable </li></ul><ul><ul><ul><li>↓  Baro rece...
POSTURAL ORTHOSTATIC TACHYCARDIA  SYNDROME  (POTS) <ul><li>Patients ( women 15-50) </li></ul><ul><li>dizziness or faint on...
Initial evaluation: History <ul><li>Prior to event </li></ul><ul><li>Position, activity, situation (urinating etc) </li></...
Diagnostic tests <ul><li>Carotid sinus massage </li></ul><ul><li>Tilt testing </li></ul><ul><li>Others; EP testing, signal...
Carotid Sinus Massage Protocol <ul><li>Massage longitudinally, site of maximal impulse, anterior margin SCM muscle level o...
Carotid Sinus Massage <ul><li>Stimulation of hypersensitive carotid body can produce 3 main responses </li></ul><ul><ul><l...
Positive CSM Test <ul><li>Significant brady /more  than 3 s pause  on the ECG  </li></ul><ul><li>More than 50 mmHg fall in...
TILT TABLE TEST
Tilt Table Test In Action
Indications for Tilt Table Testing <ul><li>Unexplained recurrent syncope </li></ul><ul><li>Assessment of recurrent, unexpl...
Upright Tilt Table Test <ul><li>Measure HR and BP while tilting them upright </li></ul><ul><li>Attempt to elicit symptoms ...
Tilt Table Testing <ul><li>Supine at least 20 minutes prior to tilt </li></ul><ul><li>Tilt angle  70 degrees </li></ul><ul...
Normal test
Cardioinhibitory response
Vasodepressor response BP drops from 150/70 to 50/30 but heart rate stays same
Mixed response BP drops from 150/60 to 50/20 while HR drops from 65 to 30bpm
 
Orthostatic hypotension steady drop in BP and rise in HR
Heart Monitoring Options Syncope Occurs Infrequently,  Long-term Monitoring is Likely to be Most Effective ILR MCOT Extern...
 
Everything is spinning
MANAGEMENT <ul><li>Patient education and counselling </li></ul><ul><li>Avoid triggers </li></ul><ul><li>Increase in salt a...
Postural hypotension <ul><li>Exclude treatable causes  – then: </li></ul><ul><ul><li>Education </li></ul></ul><ul><ul><li>...
Pharmacological  therapy <ul><li>Beta blockers </li></ul><ul><li>Dysopyramide </li></ul><ul><li>Fludrocortisone </li></ul>...
Management of Neurally Mediated Syncope Grubb BP.  NEJM.  2005.  352(10): 1004-1010
INDICATION  FOR  PACEMAKER  <ul><li>Syncope with cardio inhibitory or mixed (cardio-inhibitory plus vasodepressor). </li><...
What are the indications for pacemaker therapy in neurocardiogenic syncope? <ul><li>Non-random, observational </li></ul><u...
<ul><li>27  dual-chamber pacemakers </li></ul><ul><li>  with rate-drop response </li></ul><ul><li>54 pts </li></ul><ul><li...
Soteriades E et al. N Engl J Med 2002;347:878-885 Overall Survival of Participants with Syncope, According to Cause, and P...
Driving Implications Group 1 Entitlement Group 2 Entitlement Simple faint –definite provocation with prodromal symptoms No...
SUMMARY <ul><li>Syncope is not an uncommon problem </li></ul><ul><li>The diagnosis of syncope is often missed or  it is mi...
 
ANY  QUESTION ??
 
Upcoming SlideShare
Loading in...5
×

Syncope

3,329

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
3,329
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
250
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • 1 Kenny RA, Kapoor WN. Epidemiology and social costs. In: Benditt D, Blanc J-J, et al. eds. The Evaluation and Treatment of Syncope . Elmsford, NY: Futura;2003:23-27. 2 Kapoor W. Evaluation and outcome of patients with syncope. Medicine . 1990;69:160-175. 3 Brignole M, Disertori M, Menozzi C, et al. Management of syncope referred urgently to general hospitals with and without syncope units. Europace . 2003;5:293-298. 4 Blanc J-J, L’ Her C, Touiza A, et al. Prospective evaluation and outcome of patients admitted for syncope over a 1 year period. Eur Heart J . 2002;23:815-820. 5 Campbell A, Reinken J, Allan B, et al. Falls in old age: A study of frequency and related clinical factors. Age and Ageing . 1981;10:264-270.
  • There is severe impairment of neurocardiovascular reflex which leeds to pooling of a significant of blood in the leg vessels.
  • Stimulation of baro receptors in the carotid body would send neuronal signals to NTS in the brain stem via glossopharyngeal nerve.This inturn would lead to increased parasympathetic nervous tone, inhibiting SA and AV node causing bradycardia.There is also sympathetic withdrawl leading to vasodilataion and hypotension.
  • Common in elderly and they are most vulnerable due to .. Decreased baro receptor …
  • Also known as POTS is seen in younger women who usually present dizzyness or faint on sudden standing.
  • Figure 2. Overall Survival of Participants with Syncope, According to Cause, and Participants without Syncope. P&lt;0.001 for the comparison between participants with and those without syncope. The category &amp;quot;Vasovagal and other causes&amp;quot; includes vasovagal, orthostatic, medication-induced, and other, infrequent causes of syncope.
  • Syncope

    1. 1. SYNCOPE: WHAT HAPPENS WHEN YOUR LIGHTS GO OUT ? Syed Raza MD,MRCP (UK),FCCP, Dip.Card (UK)
    2. 2. COMMON SCENARIO ! <ul><li>Elderly lady </li></ul><ul><li>Lives alone </li></ul><ul><li>Collapse at home </li></ul><ul><li>? LOC </li></ul><ul><li>No eye witness </li></ul><ul><li>Patient does not remember the event </li></ul>
    3. 3. Case Mrs L, 64yo F 66yo F , Mrs K, 59yo F Mrs M, 85yo F ? Seizure ? FA L L ? Orthostasis ? Neurocardiogenic
    4. 12. Objectives <ul><li>Definition </li></ul><ul><li>Prevalence </li></ul><ul><li>Diagnostic Work Up </li></ul><ul><li>Management </li></ul><ul><li>Implications on driving </li></ul>
    5. 13. Syncope: A Symptom, Not a Diagnosis <ul><li>Self-limited loss of consciousness and postural tone </li></ul><ul><li>Relatively rapid onset </li></ul><ul><li>Variable warning symptoms </li></ul><ul><li>Spontaneous, complete, and usually prompt recovery without medical or surgical intervention </li></ul><ul><li>Lipsitz 1983 </li></ul>Underlying mechanism: transient global cerebral hypoperfusion.
    6. 14. Impact of Syncope 1 Kenny RA, Kapoor WN. In: Benditt D, et al. eds. The Evaluation and Treatment of Syncope . Futura;2003:23-27. 2 Kapoor W. Medicine . 1990;69:160-175. 3 Brignole M, et al. Europace . 2003;5:293-298. 4 Blanc J-J, et al. Eur Heart J . 2002;23:815-820. 5 Campbell A, et al. Age and Ageing . 1981;10:264-270. <ul><li>40% will experience syncope at least once in a lifetime 1 </li></ul><ul><li>1-6% of hospital admissions 2 </li></ul><ul><li>1% of emergency room visits per year 3,4 </li></ul><ul><li>10% of falls by elderly are due to syncope 5 </li></ul><ul><li>Major morbidity reported in 6% 1 eg, fractures, motor vehicle accidents </li></ul><ul><li>Minor injury in 29% 1 eg, lacerations, bruises </li></ul>
    7. 15. THE COST <ul><li>More than 1 billion pounds per year spent by NHS for managing falls and syncope. </li></ul><ul><li>Significant portion of the budget is spent on </li></ul><ul><li>clinical conditions which have been misdiagnosed ( i.e. 10% of syncope diagnosed as epilepsy) </li></ul>
    8. 16. Incidence Rates of Syncope According to Age and Sex Soteriades, E. et al. N Engl J Med 2002;347:878-885
    9. 18. Classification Syncope Neurally Mediated 34% Vasovagal Carotid Sinus Situational Glossopharyngeal Neuralgia Cerebrovascular Autonomic Failure Cardiac Mediated 18% Arrythmia Srtructural Heart Disease Cardiopulmonary Disease Others 47% Orthostatic Hypotension Idiopathic Medications Psychiatric
    10. 19. Causes of syncope* <ul><li>Neurally mediated 50% </li></ul><ul><li>Cardiac arrhythmia 11% </li></ul><ul><li>Orthostatic hypotension 6% </li></ul><ul><li>Structural cardiopulmonary 3% </li></ul><ul><li>Unknown 9% </li></ul>* Data pooled from 4 population studies n=1640 patients
    11. 20. Neurally Mediated Syncope <ul><li>Neuro cardiogenic syncope </li></ul><ul><li>Carotid sinus hypersensitivity </li></ul><ul><li>Visceral syncope (micturition, cough, defecation etc.) </li></ul><ul><li>Glossopharyngeal neuralgia </li></ul>
    12. 21. Neurally Mediated Syncope (autonomic failure) <ul><li>Orthostatic /Postural Hypotension </li></ul><ul><li>Postural Orthostatic Tachycardia Syndrome (POTS) </li></ul>
    13. 22. Neuro-Cardiogenic Syncope <ul><li>Commonest cause of syncope </li></ul><ul><li>Most frequently in 30 - 50 age group </li></ul><ul><li>Typical triggers - pain, fear, blood etc </li></ul><ul><li>Prodromal symptoms- warmth, nausea, sweating </li></ul><ul><li>Good history is key to diagnosis </li></ul><ul><li>Usually does not require fancy investigations </li></ul><ul><li>Patient may be discharged the same day </li></ul>
    14. 23. Pathophysiology <ul><li>Neuro-cardiovascular reflexes severely impaired or absent. </li></ul><ul><li>Pooling of 500-800 ml blood in distensible blood vessels of legs on prolonged standing. </li></ul><ul><li>Reduced venous return and cardiac output. </li></ul><ul><li>Reduced brain perfusion. </li></ul><ul><li>Warning signals to brain impaired </li></ul><ul><li>Patient presents with pre syncope or syncope </li></ul>
    15. 24. Carotid Sinus Syndrome <ul><li>Common in elderly/atherosclerotic ds. </li></ul><ul><li>Sensitive baro receptors at carotid body </li></ul><ul><li>Any pressure i.e. sudden neck turning </li></ul><ul><li>or tight collar /shaving </li></ul><ul><li>slowing of heart rate and fall in blood pressure </li></ul><ul><li>Poor brain perfusion -> Syncope </li></ul>
    16. 25. Carotid Sinus Syncope and Autonomic Dysfunction Freeman, M. Neurogenic Orthostatic Hypotension. NEJM 2008; 358: 616
    17. 27. POSTURAL BP
    18. 29. Postural Blood Pressure <ul><li>Sadly NOT accurately measured </li></ul><ul><li>Supine position –at least 10 minutes </li></ul><ul><li>Standing/Sitting </li></ul><ul><li>Measure BP immediately, 1 minute , 3 minutes </li></ul><ul><li>Symptoms of pre-syncope or syncope </li></ul><ul><li>Fall in systolic BP by 30 mmHg AND diastolic BP by 20 mmHg . </li></ul>
    19. 30. Orthostatic Hypotension <ul><li>Common in elderly </li></ul><ul><li>most vulnerable </li></ul><ul><ul><ul><li>↓ Baro receptor sensitivity </li></ul></ul></ul><ul><ul><ul><li>Reduced thirst mechanism </li></ul></ul></ul><ul><ul><ul><li>Poly pharmacy </li></ul></ul></ul><ul><li>Peripheral sympathetic tone impairment </li></ul><ul><ul><ul><li>Diabetic neuropathy, antihypertensive medication </li></ul></ul></ul>
    20. 31. POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) <ul><li>Patients ( women 15-50) </li></ul><ul><li>dizziness or faint on acquiring sudden erect posture </li></ul><ul><li>Reduced volume of blood reaches the heart </li></ul><ul><li>Stimulation of mechano receptors causes tachycardia </li></ul><ul><li>Heart rate increases by more than 30 beats/min. </li></ul><ul><li>Heart rate usually above 120 /minute. </li></ul>
    21. 32. Initial evaluation: History <ul><li>Prior to event </li></ul><ul><li>Position, activity, situation (urinating etc) </li></ul><ul><li>predisposing factors (crowded, warm place etc) </li></ul><ul><li>precipitating events (fear, pain, neck movements) </li></ul><ul><li>Onset of event </li></ul><ul><li>nausea, vomiting, sweating, aura, </li></ul><ul><li>About event (eye witness) </li></ul><ul><li>Colour, duration, movements, tongue biting </li></ul><ul><li>After the event </li></ul><ul><li>nausea, vomiting, sweating, confusion, muscle ache, skin colour, wounds </li></ul>
    22. 33. Diagnostic tests <ul><li>Carotid sinus massage </li></ul><ul><li>Tilt testing </li></ul><ul><li>Others; EP testing, signal averaged (V) ECG, Echocardiography, ETT, cardiac catheterisation, neurological/psychiatric evaluation, </li></ul>
    23. 34. Carotid Sinus Massage Protocol <ul><li>Massage longitudinally, site of maximal impulse, anterior margin SCM muscle level of cricoid cartilage </li></ul><ul><li>5 –10 seconds, right first, then left after 1-2 minute break ( Newcastle protocol 10secs ) </li></ul><ul><li>Continuous ECG and BP monitoring mandatory </li></ul><ul><li>Neurological complication in 0.45% in a series of 1600 patients (5secs massage) </li></ul>
    24. 35. Carotid Sinus Massage <ul><li>Stimulation of hypersensitive carotid body can produce 3 main responses </li></ul><ul><ul><li>Cardio-inhibitory response (70%) </li></ul></ul><ul><ul><li>Vasodepressor response (10%) </li></ul></ul><ul><ul><li>Mixed (20%) </li></ul></ul>
    25. 36. Positive CSM Test <ul><li>Significant brady /more than 3 s pause on the ECG </li></ul><ul><li>More than 50 mmHg fall in systolic BP </li></ul><ul><li>Mixed response </li></ul>
    26. 37. TILT TABLE TEST
    27. 38. Tilt Table Test In Action
    28. 39. Indications for Tilt Table Testing <ul><li>Unexplained recurrent syncope </li></ul><ul><li>Assessment of recurrent, unexplained fall </li></ul><ul><li>Syncope with suspected autonomic failure </li></ul><ul><li>After a cardiac cause for syncope has been excluded </li></ul>
    29. 40. Upright Tilt Table Test <ul><li>Measure HR and BP while tilting them upright </li></ul><ul><li>Attempt to elicit symptoms </li></ul>
    30. 41. Tilt Table Testing <ul><li>Supine at least 20 minutes prior to tilt </li></ul><ul><li>Tilt angle 70 degrees </li></ul><ul><li>Passive phase min 20 to 45 minutes </li></ul><ul><li>Use either intravenous isoprenaline or sublingual GTN if passive phase is negative </li></ul><ul><li>Pharmacological phase – 15 to 20 minutes </li></ul><ul><li>End-point: induction syncope </li></ul>
    31. 42. Normal test
    32. 43. Cardioinhibitory response
    33. 44. Vasodepressor response BP drops from 150/70 to 50/30 but heart rate stays same
    34. 45. Mixed response BP drops from 150/60 to 50/20 while HR drops from 65 to 30bpm
    35. 47. Orthostatic hypotension steady drop in BP and rise in HR
    36. 48. Heart Monitoring Options Syncope Occurs Infrequently, Long-term Monitoring is Likely to be Most Effective ILR MCOT External Loop Recorder Typical Event Recorder Holter Monitor 12-Lead 2 Days 7 Days 30+ Days 36 Months 10 Seconds ILR = insertable loop recorder MCOT= mobile cardiac outpatient telemetry
    37. 50. Everything is spinning
    38. 51. MANAGEMENT <ul><li>Patient education and counselling </li></ul><ul><li>Avoid triggers </li></ul><ul><li>Increase in salt and fluid intake </li></ul><ul><li>Sleeping with the head of the bed raised (6-12 inches. </li></ul><ul><li>Elastic stockings </li></ul><ul><li>Preventing LOC or Injury </li></ul><ul><ul><ul><li>Assume supine position upon onset of prodrome </li></ul></ul></ul><ul><ul><ul><li>Avoid driving or other activities that could lead to injury </li></ul></ul></ul>
    39. 52. Postural hypotension <ul><li>Exclude treatable causes – then: </li></ul><ul><ul><li>Education </li></ul></ul><ul><ul><li>Raise bed head </li></ul></ul><ul><ul><li>Compression stockings </li></ul></ul><ul><ul><li>Increase salt intake </li></ul></ul><ul><ul><li>Fludrocortisone – 50 mcg nocte initially </li></ul></ul><ul><ul><li>Flurbiprofen </li></ul></ul><ul><ul><li>Desmopressin </li></ul></ul><ul><ul><li>Midodrine – oral alpha agonist </li></ul></ul>
    40. 53. Pharmacological therapy <ul><li>Beta blockers </li></ul><ul><li>Dysopyramide </li></ul><ul><li>Fludrocortisone </li></ul><ul><li>SSRIs </li></ul><ul><li>Midodrine </li></ul>
    41. 54. Management of Neurally Mediated Syncope Grubb BP. NEJM. 2005. 352(10): 1004-1010
    42. 55. INDICATION FOR PACEMAKER <ul><li>Syncope with cardio inhibitory or mixed (cardio-inhibitory plus vasodepressor). </li></ul><ul><li>Severe brady cardia, AV or SA block </li></ul><ul><li>Over drive pacing for some tachy arrhythmia. </li></ul>
    43. 56. What are the indications for pacemaker therapy in neurocardiogenic syncope? <ul><li>Non-random, observational </li></ul><ul><li>RCTs comparing vs </li></ul><ul><li>RCTs comparing vs </li></ul>
    44. 57. <ul><li>27 dual-chamber pacemakers </li></ul><ul><li> with rate-drop response </li></ul><ul><li>54 pts </li></ul><ul><li>27 No pacemaker </li></ul>The North American Vasovagal Pacemaker Study (VPS) <ul><li>Included </li></ul><ul><li>>6 lifetime episodes </li></ul><ul><li>+ tilt-table test </li></ul><ul><ul><li>(relative bradycardia) </li></ul></ul>Primary outcome: first recurrence of syncope <ul><li>Excluded </li></ul><ul><li>Vascular, coronary, myocardial or conduction system disease </li></ul>J. Am. Coll Cardiol . 1999;33:16-20 Pacemaker No pacemaker Recurrence of Syncope 6/27 (22%) 19/27 (70%) Time to recurrence 112 days 54 days
    45. 58. Soteriades E et al. N Engl J Med 2002;347:878-885 Overall Survival of Participants with Syncope, According to Cause, and Participants without Syncope
    46. 59. Driving Implications Group 1 Entitlement Group 2 Entitlement Simple faint –definite provocation with prodromal symptoms No driving restrictions No driving restrictions Unexplained syncope with low risk of recurrence Can drive 4 weeks after the event Can drive 3 months after the event Unexplained syncope & high risk of recurrence A abnormal ECG B structural heart disease C syncope at the wheel or results in injury D more than 1 episode in last 6 months Can drive 4 weeks after the event if cause identified and treated If no cause – 6 months off Can drive after 3 months if the cause identified and treated If no cause, licence revoked for year Loss of consciousness with no clinical pointers Full neuro/cardiac Ix with no pointers Licence revoked for 6 months Licence revoked for 1 year Cough syncope Stop driving until symptoms controlled Stop driving If smokes or respiratory disease have to be controlled for 5 years
    47. 60. SUMMARY <ul><li>Syncope is not an uncommon problem </li></ul><ul><li>The diagnosis of syncope is often missed or it is misdiagnosed </li></ul><ul><li>Thorough history from eye witness can be very helpful </li></ul><ul><li>Syncope can be fatal </li></ul><ul><li>Further training to identify the problem and formulating a plan of management is needed. </li></ul>
    48. 62. ANY QUESTION ??
    1. A particular slide catching your eye?

      Clipping is a handy way to collect important slides you want to go back to later.

    ×